IL143570A0 - Synthesis of histamine dihydrochloride - Google Patents

Synthesis of histamine dihydrochloride

Info

Publication number
IL143570A0
IL143570A0 IL14357099A IL14357099A IL143570A0 IL 143570 A0 IL143570 A0 IL 143570A0 IL 14357099 A IL14357099 A IL 14357099A IL 14357099 A IL14357099 A IL 14357099A IL 143570 A0 IL143570 A0 IL 143570A0
Authority
IL
Israel
Prior art keywords
histamine dihydrochloride
invention disclosed
synthesis
dihydrochloride
smallcaps
Prior art date
Application number
IL14357099A
Other languages
English (en)
Original Assignee
Maxim Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Maxim Pharm Inc filed Critical Maxim Pharm Inc
Publication of IL143570A0 publication Critical patent/IL143570A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/145555—Hetero-N
    • Y10T436/147777—Plural nitrogen in the same ring [e.g., barbituates, creatinine, etc.]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL14357099A 1998-12-23 1999-12-20 Synthesis of histamine dihydrochloride IL143570A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11393398P 1998-12-23 1998-12-23
PCT/US1999/030379 WO2000039098A1 (en) 1998-12-23 1999-12-20 Synthesis of histamine dihydrochloride
US09/467,652 US6403806B1 (en) 1998-12-23 1999-12-20 Synthesis of histamine dihydrochloride

Publications (1)

Publication Number Publication Date
IL143570A0 true IL143570A0 (en) 2002-04-21

Family

ID=26811642

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14357099A IL143570A0 (en) 1998-12-23 1999-12-20 Synthesis of histamine dihydrochloride
IL143570A IL143570A (en) 1998-12-23 2001-06-05 Synthesis of histamine dihydrochloride

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL143570A IL143570A (en) 1998-12-23 2001-06-05 Synthesis of histamine dihydrochloride

Country Status (17)

Country Link
US (3) US6403806B1 (pt)
EP (1) EP1140857B1 (pt)
JP (1) JP4139082B2 (pt)
CN (1) CN1155579C (pt)
AT (1) ATE399769T1 (pt)
AU (1) AU763523B2 (pt)
CA (1) CA2356871C (pt)
DE (1) DE69939027D1 (pt)
DK (1) DK1140857T3 (pt)
ES (1) ES2310056T3 (pt)
HK (1) HK1040998B (pt)
IL (2) IL143570A0 (pt)
NZ (1) NZ512935A (pt)
PT (1) PT1140857E (pt)
TW (1) TWI243166B (pt)
WO (1) WO2000039098A1 (pt)
ZA (1) ZA200104552B (pt)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6590106B2 (en) * 1997-05-09 2003-07-08 Pharm-Eco Laboratories, Inc. Amino acid derivatives and methods of making the same
BRPI0506807A (pt) * 2004-04-22 2007-05-29 Mor Research Applic Ltd método de gerenciamento de consumo de alimento e composição farmacológica
US7728015B2 (en) * 2004-04-22 2010-06-01 Mor Research Applications Ltd. Compositions for weight management
US20080051440A1 (en) * 2004-04-22 2008-02-28 Mor Research Applications Ltd. Compositions for weight management
US20060188528A1 (en) * 2005-02-23 2006-08-24 Ansell Healthcare Products Llc Spreadable warming lubricant
US7709428B2 (en) * 2005-02-23 2010-05-04 Ansell Healthcare Products Llc Thickened spreadable warming lubricant
DE102006060908A1 (de) * 2006-12-20 2008-07-03 Evonik Degussa Gmbh Kontinuierliches Verfahren zur Decarboxylierung von Carbonsäuren
US8770201B2 (en) * 2007-10-26 2014-07-08 Glycobiosciences Inc. Condom with multifunctional coating
CN102477014B (zh) * 2010-11-27 2015-08-19 山东新时代药业有限公司 二盐酸组胺的制备方法
ITMI20110379A1 (it) * 2011-03-10 2012-09-11 Erregierre Spa Procedimento per la preparazione di istamina dicloridrato con elevato grado di purezza
US10118898B2 (en) 2013-03-14 2018-11-06 University Of Georgia Research Foundation, Inc. Method for decarboxylation of amino acids via imine formation
US9452954B2 (en) 2013-03-14 2016-09-27 University Of Georgia Research Foundation, Inc. Method for decarboxylation of amino acids via imine formation
US10487042B2 (en) 2013-03-14 2019-11-26 University Of Georgia Research Foundation, Inc. Method for solvent-free decarboxylation of amino acids via imine formation
CN103288742A (zh) * 2013-06-04 2013-09-11 四川百利药业有限责任公司 一种高纯度英加韦林原料的制备方法
CN103739551B (zh) * 2013-09-24 2016-03-23 国药一心制药有限公司 一种二盐酸组胺的纯化方法
JP6495288B2 (ja) * 2013-12-17 2019-04-03 サイモン フレーザー ユニバーシティー トコジラミを誘引および／または拘束するための化合物、組成物、および方法
CN103739552B (zh) * 2014-01-24 2015-08-26 国药一心制药有限公司 二盐酸组胺的制备方法
CN104402825B (zh) * 2014-12-13 2017-03-15 济南诚汇双达化工有限公司 一种组胺二盐酸盐的合成方法
CN106432089B (zh) * 2016-09-12 2018-09-07 开封制药(集团)有限公司 二盐酸组胺的合成方法
WO2019008594A1 (en) * 2017-07-03 2019-01-10 Jubilant Generics Limited CONTINUOUS PROCESS FOR THE PREPARATION OF 2- (1H-IMIDAZOL-4-YL) ETHANAMINE AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS
US10889549B2 (en) 2017-07-03 2021-01-12 Jubilant Generics Limited Continuous process for the preparation of 2-(1H-imidazol-4-yl) ethanamine and pharmaceutically acceptable salts thereof
CN112266360B (zh) * 2020-10-26 2022-06-10 武汉桀升生物科技有限公司 一种高纯度组胺二盐酸盐的合成方法
CN113045500A (zh) * 2021-03-31 2021-06-29 苏州园方生物科技有限公司 一种组胺二盐酸盐的制备方法
JP7193815B1 (ja) 2021-12-28 2022-12-21 Ｋｍバイオロジクス株式会社 ヒスタミンの製造方法及び医薬品としてのその使用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE56793C (de) O. ECKARDT in Berlin Verfahren zur Herstellung von Steinkohlenbriquets auf kaltem Wege
GB430108A (en) * 1934-02-23 1935-06-13 Boot S Pure Drug Company Ltd Improvements relating to the preparation of histamine and its derivatives
GB1008594A (en) 1963-07-03 1965-10-27 Nat Res Dev Process for the production of amines
SU557755A3 (ru) * 1968-08-19 1977-05-05 Янссен Фармасьютика Н.В. (Фирма) Способ получени производных имидазола
DE3322117A1 (de) * 1983-06-20 1984-12-20 Diamalt AG, 8000 München Verfahren zur herstellung von n(pfeil hoch)(tau)(pfeil hoch)-substituierten histidinderivaten, n(pfeil hoch)(tau)(pfeil hoch)-substituierten histidinderivate und ihre verwendung
NL8800998A (nl) * 1988-04-18 1989-11-16 Cedona Pharm Bv Werkwijze voor het bereiden van een al of niet gesubstitueerd 4(5)-(omega-aminoalkyl) imidazool.
JPH05255204A (ja) 1992-03-11 1993-10-05 Kanegafuchi Chem Ind Co Ltd アミン類の製造法
SE513429C2 (sv) 1992-06-03 2000-09-11 Syntello Inc Preparat för aktivering av naturliga mördarceller, vilket preparat innehåller interferon alfa och biogena aminer

Also Published As

Publication number Publication date
CA2356871C (en) 2010-09-14
EP1140857B1 (en) 2008-07-02
DE69939027D1 (de) 2008-08-14
DK1140857T3 (da) 2008-10-20
CN1331681A (zh) 2002-01-16
US20020035268A1 (en) 2002-03-21
AU2482500A (en) 2000-07-31
CA2356871A1 (en) 2000-07-06
TWI243166B (en) 2005-11-11
US20030138964A1 (en) 2003-07-24
JP2002533445A (ja) 2002-10-08
ZA200104552B (en) 2002-01-16
US6528654B2 (en) 2003-03-04
ES2310056T3 (es) 2008-12-16
WO2000039098A9 (en) 2001-05-17
HK1040998B (zh) 2009-04-24
AU763523B2 (en) 2003-07-24
PT1140857E (pt) 2008-10-06
WO2000039098A1 (en) 2000-07-06
JP4139082B2 (ja) 2008-08-27
IL143570A (en) 2006-08-20
NZ512935A (en) 2003-08-29
EP1140857A1 (en) 2001-10-10
US6620942B2 (en) 2003-09-16
CN1155579C (zh) 2004-06-30
US6403806B1 (en) 2002-06-11
ATE399769T1 (de) 2008-07-15
HK1040998A1 (en) 2002-06-28

Similar Documents

Publication Publication Date Title
HK1040998A1 (en) Synthesis of histamine dihydrochloride
PL392725A1 (pl) Nowe związki pośrednie do syntezy związków triazolopirymidyny oraz sposób ich wytwarzania
IL114599A (en) Substituted pyrimidine compounds their preparation and pharmaceutical compositions containg them
HUP0402150A3 (en) 1h-imidazole derivatives having cb1 agonistic, cb1 partial agonistic or cb1-antagonistic activity, process for the preparation, pharmaceutical compositions containing them and their use for production of pharmaceutical compositions
HUP0002031A3 (en) Use of benzotiophen derivatives for production pharmaceutical compositions having activity against central nervous system disorders
IL214164A0 (en) Process for the preparation of intermediates useful in the synthesis of statin derivatives especially 7-amino 3,5-dihydroxy heptanoic acid derivatives, and intermediates thereof
HUP0001945A3 (en) Dibenzocycloheptene derivatives as vitronectin receptor antagonists, process for producing them and pharmaceutical copositions containing them
HUP0202103A2 (en) 8-phenyl-6,9-dihydro-[1,2,4]triazolo[3,4-i]purin-5-one derivatives, their use, pharmaceutical compositions containing them, process for the preparation of the compounds and intermediates
HUP0203496A3 (en) Novel cyclopropane derivatives, pharmaceutical compositions containing them and method for the production thereof
HUP0200284A2 (en) 1-arenesulfonyl-2-aryl-pyrrolidine and piperidine derivatives for the treatment of cns disorders, process for their preparation and pharmaceutical compositions containing them
HUP0101143A3 (en) Pyridin-carboxylic acid derivatives as vitronectin receptor antagonists, process for producing them and pharmaceutical compositions containing them
WO1996023769A3 (en) Heterocyclic compounds possessing 5ht2c receptor antagonist activity
SE0100824D0 (sv) Method III to obtain microparticles
AU6329799A (en) Pharmaceutical preparation for use in a method to abate the use of tobacco by humans
HUP0202706A3 (en) Benzisoxazolyl-, pyridoisoxazolyl- and benzthienyl-phenoxy derivatives useful as d4 antagonists, their intermediates, process for their preparation and pharmaceutical compositions containing them
PL310950A1 (en) Novel imidazole quinoxalinones, method of obtaining them and their application
HUP9900883A3 (en) Amino acid derivatives of substituted quinoxaline 2,3-dione derivatives as glutamate receptor antagonists
HK1051845A1 (en) Substituted 1 and 2 naphthol mannich bases
CY1108379T1 (el) Συνθεση της διυδροχλωρικης ισταμινης
MXPA04000953A (es) Derivados sustituidos del acido 5,6,6a,11b-tetrahidro-7-oxa-aza-benzo[c]fluoren-6-carboxilico como antagonista de nmda.
ATE360611T1 (de) 2,3,3a,4,9,9a-hexahydro-8-hydroxy-1h- benz(f)indole, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
AU2003290118A1 (en) Method for the continuous production of intermediate products in order to obtain 3-hydroxypyridine compounds
BG99062A (en) POLYMORPH "A" OF N-t-BUTYL-ANDROST-3,5-DIENE-17 -CARBOXAMIDE-3-CARBOXYLIC ACID
TW200514557A (en) Pharmaceutically acceptable salt of amlodipine and method of preparing the same
HUP0300192A3 (en) Method for production of 1,3-disubstituted 2-nitroguanidines

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed